The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...

Parliamentary panel slams drug pricing regulator for hike on 11 drugs used for treating conditions such as asthma, glaucoma, ...

This article critically reviews clinical trial data of novel anti-inflammatory drugs in asthma, encompassing specific anti-eosinophil therapies, including antisense chemokine receptor antagonists ...

Glucocorticoids (GCs) are widely used medications to treat inflammation caused by conditions like arthritis, asthma, ...

MANY chronic asthmatics state that they obtain relief from proprietary asthma powders available in Germany without medical prescription. Most of these powders contain either phenazone or ...

The U.S. Department of Health and Human Services announced Friday it will award $306 million in additional funding to monitor ...

Earlier research by the same group had found that starting anti-TNF drugs as a first line of treatment reduced the likelihood of the patient developing a perianal fistula by about 60%. (And among ...

Frevecitinib is under clinical development by Kinaset Therapeutics and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR ...